The second most-frequent genetic lesions found in patients with Noonan syndrome are mutations in the RAS-GEF SOS1, which abrogate the SOS1 autoinhibitory function and result in its constitutive activation (Roberts et al., 2007; Tartaglia et al., 2007). This evidence concerns the gene SOS1 and Noonan syndrome.